【药明康德回应关税等问题：影响极不明朗，暂维持全年指引】金十数据4月11日讯，在4月10日的业绩说明会上，针对美国总统特朗普宣布将对药品征收关税、美国新兴生物技术国家安全委员会（NSCEB）近日在一份报告中称药明康德“深度嵌入美国生物医药供应链”等话题，药明康德进行了回应，表示“对等关税”目前影响还极不明朗，并维持公司全年指引；前述报告中对公司的指称“牵强附会且毫无根据”。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.